Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio.
Open Access
- 1 December 1988
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 26 (6) , 791-795
- https://doi.org/10.1111/j.1365-2125.1988.tb05321.x
Abstract
1. The debrisoquine hydroxylation phenotype was assessed in 211 healthy subjects of Finnish Caucasian origin. 2. A bimodal distribution was observed in the urinary debrisoquine/4-hydroxydebrisoquin ratio. Eleven subjects (about 5%) were poor metabolizers of debrisoquine, when a ratio of 12.6 was used as the cut-off point. 3. The mean metabolic ratio of 35 extensive metabolizers taking oral contraceptives was slightly lower than that of extensive metabolizers not taking contraceptives. This indicates that oral contraceptives may change the phenotyping near the metabolic ratio of 12.6. 4. The metabolic ratios were determined in eight subjects using both 4 h and 6 h urine collection times. The metabolic ratios corresponded well with each other indicating the usefulness of the shorter 4 h collection time.Keywords
This publication has 15 references indexed in Scilit:
- Characterization of the common genetic defect in humans deficient in debrisoquine metabolismNature, 1988
- Debrisoquine oxidation in an Australian population.British Journal of Clinical Pharmacology, 1986
- 2-Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine.Published by Wiley ,1984
- METABOLISM OF PROGESTERONE AND ESTRADIOL BY MICROSOMES AND PURIFIED CYTOCHROME-P-450 CYTOCHROME-RLM3 AND CYTOCHROME-RLM51984
- Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entitiesClinical Pharmacology & Therapeutics, 1982
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- The disposition of debrisoquine in hypertensive patients.British Journal of Clinical Pharmacology, 1978
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINEThe Lancet, 1977
- Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detectionJournal of Chromatography A, 1977